{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:34:59Z","timestamp":1788435299925,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["3402807"],"award-info":[{"award-number":["3402807"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-024-08339-8","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T09:03:13Z","timestamp":1722502993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The effect of astaxanthin supplementation on inflammatory markers, oxidative stress indices, lipid profile, uric acid level, blood pressure, endothelial function, quality of life, and disease symptoms in heart failure subjects"],"prefix":"10.1186","volume":"25","author":[{"given":"Shirin Ghotbbodin","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awat","family":"Feizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Bagherniya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Shafie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali-Reza","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marziyeh","family":"Kafeshani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"issue":"1","key":"8339_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12872-022-02683-w","volume":"22","author":"N Baeradeh","year":"2022","unstructured":"Baeradeh N, Ghoddusi Johari M, Moftakhar L, Rezaeianzadeh R, Hosseini SV, Rezaianzadeh A. The prevalence and predictors of cardiovascular diseases in Kherameh cohort study: a population-based study on 10,663 people in southern Iran. BMC Cardiovasc Disord. 2022;22(1):244.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"8339_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13561-023-00457-4","volume":"13","author":"R Ravangard","year":"2023","unstructured":"Ravangard R, Jalali FS, Hajahmadi M, Jafari A. Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran. Heal Econ Rev. 2023;13(1):44.","journal-title":"Heal Econ Rev"},{"issue":"2","key":"8339_CR3","first-page":"76","volume":"1","author":"S Zeighami Mohammadi","year":"2018","unstructured":"Zeighami Mohammadi S, Farmani P, Shakoor M, Fahidy F, Fallah Taherpazir E, Mohseni B. Correlation between type D personality and quality of life in heart failure patients. International Journal of Biomedicine and Public Health. 2018;1(2):76\u201381.","journal-title":"International Journal of Biomedicine and Public Health"},{"issue":"3","key":"8339_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","volume":"129","author":"AS Go","year":"2014","unstructured":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Executive summary: heart disease and stroke statistics\u20132014 update: a report from the American Heart Association. Circulation. 2014;129(3):399\u2013410.","journal-title":"Circulation"},{"issue":"8","key":"8339_CR5","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ejhf.1858","volume":"22","author":"A Groenewegen","year":"2020","unstructured":"Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342\u201356.","journal-title":"Eur J Heart Fail"},{"issue":"7229","key":"8339_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1136\/bmj.320.7229.236","volume":"320","author":"RD Watson","year":"2000","unstructured":"Watson RD, Gibbs CR, Lip GY. ABC of heart failure. Clinical features and complications BMJ (Clinical research ed). 2000;320(7229):236\u20139.","journal-title":"Clinical features and complications BMJ (Clinical research ed)"},{"issue":"11","key":"8339_CR7","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.cardfail.2020.08.015","volume":"26","author":"M Packer","year":"2020","unstructured":"Packer M. Uric Acid Is a Biomarker of Oxidative Stress in the Failing Heart: Lessons Learned from Trials With Allopurinol and SGLT2 Inhibitors. J Cardiac Fail. 2020;26(11):977\u201384.","journal-title":"J Cardiac Fail"},{"issue":"3","key":"8339_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1527-5299.2002.00715.x","volume":"8","author":"CD Searles","year":"2002","unstructured":"Searles CD. The nitric oxide pathway and oxidative stress in heart failure. Congest Heart Fail (Greenwich, Conn). 2002;8(3):142\u20137, 55.","journal-title":"Congest Heart Fail (Greenwich, Conn)"},{"issue":"6","key":"8339_CR9","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/heart.88.6.564","volume":"88","author":"JM Cotton","year":"2002","unstructured":"Cotton JM, Kearney MT, Shah AM. Nitric oxide and myocardial function in heart failure: friend or foe? Heart (British Cardiac Society). 2002;88(6):564\u20136.","journal-title":"Heart (British Cardiac Society)"},{"issue":"3","key":"8339_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/CS20080581","volume":"117","author":"J Niu","year":"2009","unstructured":"Niu J, Kolattukudy PE. Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Clin Sci.\u00a0 (London, England\u202f: 1979). 2009;117(3):95\u2013109.","journal-title":"Clin Sci.\u00a0 (London, England : 1979)"},{"issue":"1","key":"8339_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.clnu.2010.07.008","volume":"30","author":"M Makarewicz-Wujec","year":"2011","unstructured":"Makarewicz-Wujec M, Kozlowska-Wojciechowska M. Nutrient intake and serum level of gamma-glutamyltransferase, MCP-1 and homocysteine in early stages of heart failure. Clinical nutrition (Edinburgh, Scotland). 2011;30(1):73\u20138.","journal-title":"Clinical nutrition (Edinburgh, Scotland)"},{"key":"8339_CR12","first-page":"1113","volume-title":"Atherogenic index of plasma [log (triglycerides\/HDL-cholesterol)]: theoretical and practical implications","author":"M Dobias\u02c7ova","year":"2004","unstructured":"Dobias\u02c7ova M. Atherogenic index of plasma [log (triglycerides\/HDL-cholesterol)]: theoretical and practical implications. Oxford University Press; 2004. p. 1113\u20135."},{"key":"8339_CR13","first-page":"240","volume":"29","author":"S Niroumand","year":"2015","unstructured":"Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, Abrishami M, Juya M, Khodaee G, et al. Atherogenic Index of Plasma (AIP): A marker of cardiovascular disease. Med J Islam Repub Iran. 2015;29:240.","journal-title":"Med J Islam Repub Iran"},{"issue":"3","key":"8339_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2217\/bmm-2018-0196","volume":"13","author":"MK Karada\u011f","year":"2019","unstructured":"Karada\u011f MK, Y\u0131ld\u0131r\u0131m E. Relationship of atherogenic index of plasma and mean platelet volume with ejection fraction in ischemic and nonischemic heart failure. Biomark Med. 2019;13(3):175\u201383.","journal-title":"Biomark Med"},{"key":"8339_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4103\/rcm.rcm_16_21","volume":"10","author":"S Mondal","year":"2021","unstructured":"Mondal S, Mondal H, Samantaray R, Das D, Biri S, Naskar A, et al. Atherogenic index of plasma and left ventricular ejection fraction in newly diagnosed type 2 diabetes mellitus patients. Research in Cardiovascular Medicine. 2021;10:73\u20138.","journal-title":"Research in Cardiovascular Medicine"},{"issue":"5","key":"8339_CR16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/2047487319870344","volume":"27","author":"A Aimo","year":"2020","unstructured":"Aimo A, Castiglione V, Borrelli C, Saccaro LF, Franzini M, Masi S, et al. Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies. Eur J Prev Cardiol. 2020;27(5):494\u2013510.","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"8339_CR17","doi-asserted-by":"publisher","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","volume":"301","author":"H Tsutsui","year":"2011","unstructured":"Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol. 2011;301(6):H2181\u201390.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"8339_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ejhf.1320","volume":"21","author":"A van der Pol","year":"2019","unstructured":"van der Pol A, van Gilst WH, Voors AA, van der Meer P. Treating oxidative stress in heart failure: past, present and future. Eur J Heart Fail. 2019;21(4):425\u201335.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"8339_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/mnfr.201000414","volume":"55","author":"JP Yuan","year":"2011","unstructured":"Yuan JP, Peng J, Yin K, Wang JH. Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae. Mol Nutr Food Res. 2011;55(1):150\u201365.","journal-title":"Mol Nutr Food Res"},{"issue":"3","key":"8339_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1021\/np050354+","volume":"69","author":"G Hussein","year":"2006","unstructured":"Hussein G, Sankawa U, Goto H, Matsumoto K, Watanabe H. Astaxanthin, a carotenoid with potential in human health and nutrition. J Nat Prod. 2006;69(3):443\u20139.","journal-title":"J Nat Prod"},{"issue":"9","key":"8339_CR21","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1271\/bbb.90078","volume":"73","author":"Y Okada","year":"2009","unstructured":"Okada Y, Ishikura M, Maoka T. Bioavailability of astaxanthin in Haematococcus algal extract: the effects of timing of diet and smoking habits. Biosci Biotechnol Biochem. 2009;73(9):1928\u201332.","journal-title":"Biosci Biotechnol Biochem"},{"key":"8339_CR22","doi-asserted-by":"publisher","first-page":"104860","DOI":"10.1016\/j.jff.2021.104860","volume":"87","author":"E Mokhtari","year":"2021","unstructured":"Mokhtari E, Rafiei S, Shokri-Mashhadi N, Saneei P. Impact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Journal of Functional Foods. 2021;87:104860.","journal-title":"Journal of Functional Foods"},{"issue":"5","key":"8339_CR23","doi-asserted-by":"publisher","first-page":"e14022","DOI":"10.1111\/ijcp.14022","volume":"75","author":"N Shokri-Mashhadi","year":"2021","unstructured":"Shokri-Mashhadi N, Tahmasebi M, Mohammadi-Asl J, Zakerkish M, Mohammadshahi M. The antioxidant and anti-inflammatory effects of astaxanthin supplementation on the expression of miR-146a and miR-126 in patients with type 2 diabetes mellitus: A randomised, double-blind, placebo-controlled clinical trial. Int J Clin Pract. 2021;75(5):e14022.","journal-title":"Int J Clin Pract"},{"key":"8339_CR24","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.2147\/IJN.S439476","volume":"19","author":"JJ Chang","year":"2024","unstructured":"Chang JJ, Wang YC, Yang SH, Wu JY, Chang MW, Wang HD. Pioneering Astaxanthin-Tumor Cell Membrane Nanoparticles for Innovative Targeted Drug Delivery on Melanoma. Int J Nanomedicine. 2024;19:2395\u2013407.","journal-title":"Int J Nanomedicine"},{"issue":"5","key":"8339_CR25","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0167-7799(03)00078-7","volume":"21","author":"M Guerin","year":"2003","unstructured":"Guerin M, Huntley ME, Olaizola M. Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol. 2003;21(5):210\u20136.","journal-title":"Trends Biotechnol"},{"issue":"1","key":"8339_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/md12010128","volume":"12","author":"RR Ambati","year":"2014","unstructured":"Ambati RR, Phang SM, Ravi S, Aswathanarayana RG. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications\u2013a review. Mar Drugs. 2014;12(1):128\u201352.","journal-title":"Mar Drugs"},{"key":"8339_CR27","doi-asserted-by":"publisher","first-page":"108113","DOI":"10.1016\/j.exer.2020.108113","volume":"197","author":"H Li","year":"2020","unstructured":"Li H, Li J, Hou C, Li J, Peng H, Wang Q. The effect of astaxanthin on inflammation in hyperosmolarity of experimental dry eye model in vitro and in vivo. Exp Eye Res. 2020;197:108113.","journal-title":"Exp Eye Res"},{"issue":"1","key":"8339_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1039\/C6FO01721E","volume":"8","author":"F Visioli","year":"2017","unstructured":"Visioli F, Artaria C. Astaxanthin in cardiovascular health and disease: mechanisms of action, therapeutic merits, and knowledge gaps. Food Funct. 2017;8(1):39\u201363.","journal-title":"Food Funct"},{"issue":"2","key":"8339_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5114\/aoms.2015.50960","volume":"11","author":"S Ursoniu","year":"2015","unstructured":"Ursoniu S, Sahebkar A, Serban MC, Banach M. Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials. Archives of medical science\u202f: AMS. 2015;11(2):253\u201366.","journal-title":"Archives of medical science : AMS"},{"key":"8339_CR30","doi-asserted-by":"publisher","first-page":"105113","DOI":"10.1016\/j.phrs.2020.105113","volume":"161","author":"W Xia","year":"2020","unstructured":"Xia W, Tang N, Kord-Varkaneh H, Low TY, Tan SC, Wu X, et al. The effects of astaxanthin supplementation on obesity, blood pressure, CRP, glycemic biomarkers, and lipid profile: A meta-analysis of randomized controlled trials. Pharmacol Res. 2020;161:105113.","journal-title":"Pharmacol Res"},{"issue":"10","key":"8339_CR31","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.3390\/nu14102050","volume":"14","author":"LY Leung","year":"2022","unstructured":"Leung LY, Chan SM, Tam HL, Wong ES. Astaxanthin influence on health outcomes of adults at risk of metabolic syndrome: a systematic review and meta-analysis. Nutrients. 2022;14(10):2050.","journal-title":"Nutrients."},{"issue":"4","key":"8339_CR32","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s10815-022-02432-0","volume":"39","author":"R Gharaei","year":"2022","unstructured":"Gharaei R, Alyasin A, Mahdavinezhad F, Samadian E, Ashrafnezhad Z, Amidi F. Randomized controlled trial of astaxanthin impacts on antioxidant status and assisted reproductive technology outcomes in women with polycystic ovarian syndrome. J Assist Reprod Genet. 2022;39(4):995\u20131008.","journal-title":"J Assist Reprod Genet"},{"key":"8339_CR33","doi-asserted-by":"publisher","first-page":"1144323","DOI":"10.3389\/fendo.2023.1144323","volume":"14","author":"S Rostami","year":"2023","unstructured":"Rostami S, Alyasin A, Saedi M, Nekoonam S, Khodarahmian M, Moeini A, et al. Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: A randomized, triple-blind placebo-controlled clinical trial. Front Endocrinol. 2023;14:1144323.","journal-title":"Front Endocrinol"},{"issue":"18","key":"8339_CR34","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895\u20131032.","journal-title":"Circulation"},{"issue":"12","key":"8339_CR35","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1002\/ptr.6514","volume":"33","author":"T Brendler","year":"2019","unstructured":"Brendler T, Williamson EM. Astaxanthin: How much is too much? A safety review. Phytotherapy research\u202f: PTR. 2019;33(12):3090\u2013111.","journal-title":"Phytotherapy research : PTR"},{"issue":"2","key":"8339_CR36","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.atherosclerosis.2009.10.012","volume":"209","author":"H Yoshida","year":"2010","unstructured":"Yoshida H, Yanai H, Ito K, Tomono Y, Koikeda T, Tsukahara H, et al. Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis. 2010;209(2):520\u20133.","journal-title":"Atherosclerosis"},{"issue":"4","key":"8339_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11130-011-0258-9","volume":"66","author":"HD Choi","year":"2011","unstructured":"Choi HD, Youn YK, Shin WG. Positive effects of astaxanthin on lipid profiles and oxidative stress in overweight subjects. Plant foods for human nutrition (Dordrecht, Netherlands). 2011;66(4):363\u20139.","journal-title":"Plant foods for human nutrition (Dordrecht, Netherlands)"},{"key":"8339_CR38","first-page":"198","volume":"3","author":"T Rector","year":"1987","unstructured":"Rector T. Patient\u2019s self-assessment of their congestive heart failure: content, reliability, validity of a new measure, the Minnesota Living with Heart Failure questionnaire. Heart failure. 1987;3:198\u2013209.","journal-title":"Heart failure"},{"issue":"4","key":"8339_CR39","first-page":"475","volume":"14","author":"S Eskandari","year":"2015","unstructured":"Eskandari S, Heravi-Karimooi M, Rejeh N, Ebadi A, Montazeri A. Translation and validation study of the Iranian version of Minnesota living with heart failure questionnaire. Payesh (Health Monitor). 2015;14(4):475\u201384.","journal-title":"Payesh (Health Monitor)"},{"issue":"4","key":"8339_CR40","first-page":"395","volume":"7","author":"N Ghotbi","year":"2013","unstructured":"Ghotbi N, Ansari NN, Fetrosi S, Shamili A, Choobsaz H, Montazeri H. Fatigue in Iranian patients with neurological conditions: An assessment with Persian Fatigue Severity Scale. Health Sci J. 2013;7(4):395.","journal-title":"Health Sci J"},{"issue":"4","key":"8339_CR41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/archneur.1988.00520280085020","volume":"45","author":"LB Krupp","year":"1988","unstructured":"Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol. 1988;45(4):435\u20137.","journal-title":"Arch Neurol"},{"issue":"11","key":"8339_CR42","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.rmed.2011.05.001","volume":"105","author":"M Bosnak-Guclu","year":"2011","unstructured":"Bosnak-Guclu M, Arikan H, Savci S, Inal-Ince D, Tulumen E, Aytemir K, et al. Effects of inspiratory muscle training in patients with heart failure. Respir Med. 2011;105(11):1671\u201381.","journal-title":"Respir Med"},{"issue":"6","key":"8339_CR43","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1378\/chest.09-0934","volume":"136","author":"DA Mahler","year":"2009","unstructured":"Mahler DA, Ward J, Waterman LA, McCusker C, ZuWallack R, Baird JC. Patient-reported dyspnea in COPD reliability and association with stage of disease. Chest. 2009;136(6):1473\u20139.","journal-title":"Chest"},{"issue":"2","key":"8339_CR44","doi-asserted-by":"publisher","first-page":"e12290","DOI":"10.1111\/jjns.12290","volume":"17","author":"AH Hossein Pour","year":"2020","unstructured":"Hossein Pour AH, Gholami M, Saki M, Birjandi M. The effect of inspiratory muscle training on fatigue and dyspnea in patients with heart failure: A randomized, controlled trial. Jpn J Nurs Sci. 2020;17(2):e12290.","journal-title":"Jpn J Nurs Sci"},{"issue":"2","key":"8339_CR45","first-page":"163","volume":"8","author":"ZS Hezaveh","year":"2023","unstructured":"Hezaveh ZS, Golafrouz H, Piran A, Vafa M. Validity and reliability of the Persian version of the council on nutrition appetite questionnaire and its simplified version in Iranian community-dwelling older adults. J Nutrition Food Sec. 2023;8(2):163\u201371.","journal-title":"J Nutrition Food Sec."},{"issue":"8","key":"8339_CR46","first-page":"1073","volume":"18","author":"MB Moghaddam","year":"2012","unstructured":"Moghaddam MB, Aghdam FB, Jafarabadi MA, Allahverdipour H, Nikookheslat SD, Safarpour S. The Iranian Version of International Physical Activity Questionnaire (IPAQ) in Iran: content and construct validity, factor structure, internal consistency and stability. World Appl Sci J. 2012;18(8):1073\u201380.","journal-title":"World Appl Sci J"},{"issue":"6","key":"8339_CR47","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.3390\/nu12061896","volume":"12","author":"T Kato","year":"2020","unstructured":"Kato T, Kasai T, Sato A, Ishiwata S, Yatsu S, Matsumoto H, et al. Effects of 3-month astaxanthin supplementation on cardiac function in heart failure patients with left ventricular systolic dysfunction-a pilot study. Nutrients. 2020;12(6):1896.","journal-title":"Nutrients."},{"issue":"10a","key":"8339_CR48","doi-asserted-by":"publisher","first-page":"58d","DOI":"10.1016\/j.amjcard.2008.02.010","volume":"101","author":"FJ Pashkow","year":"2008","unstructured":"Pashkow FJ, Watumull DG, Campbell CL. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol. 2008;101(10a):58d\u201368d.","journal-title":"Am J Cardiol"},{"issue":"12","key":"8339_CR49","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1002\/ptr.3494","volume":"25","author":"HD Choi","year":"2011","unstructured":"Choi HD, Kim JH, Chang MJ, Kyu-Youn Y, Shin WG. Effects of astaxanthin on oxidative stress in overweight and obese adults. Phytotherapy research\u202f: PTR. 2011;25(12):1813\u20138.","journal-title":"Phytotherapy research : PTR"},{"issue":"2","key":"8339_CR50","first-page":"341","volume":"27","author":"NS Mashhadi","year":"2018","unstructured":"Mashhadi NS, Zakerkish M, Mohammadiasl J, Zarei M, Mohammadshahi M, Haghighizadeh MH. Astaxanthin improves glucose metabolism and reduces blood pressure in patients with type 2 diabetes mellitus. Asia Pac J Clin Nutr. 2018;27(2):341\u20136.","journal-title":"Asia Pac J Clin Nutr"},{"issue":"12","key":"8339_CR51","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.3390\/nu13124381","volume":"13","author":"M Urakaze","year":"2021","unstructured":"Urakaze M, Kobashi C, Satou Y, Shigeta K, Toshima M, Takagi M, et al. The beneficial effects of astaxanthin on glucose metabolism and modified low-density lipoprotein in healthy volunteers and subjects with prediabetes. Nutrients. 2021;13(12):4381.","journal-title":"Nutrients."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08339-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-08339-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08339-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T10:03:46Z","timestamp":1722506626000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-08339-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8339"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-08339-8","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"assertion":[{"value":"29 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethical Research Committee of Pharmacy and Nutrition Faculties at Isfahan University of Medical Sciences approved this plan (approval code: IR.MUI.MED.REC.1402.099) on 29 March 2024.This trial has been registered in the Iranian Clinical Trials Registry (ID: IRCT20200429047235N3; registered on 26 March 2024). Initially, (S.G.M.) will explain the purpose of the trial to the legal guardian and obtain their written informed consent after enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"All authors have provided their approval for publication. Permission has been obtained from the patients to publish non-identifiable information about them.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declared that there is no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"518"}}